The UK-Irish Atopic Eczema Systemic Therapy Register (A-STAR): Eli Lilly Engagement with A-STAR

Study type

• Study type:
  Non-interventional study
• Scope of the study:
  Disease epidemiology

Non-interventional study

• Non-interventional study design:
  Cohort

Study drug and medical condition

• Name of medicine:
  OLUMIANT
• Study drug International non-proprietary name (INN) or common name:
  BARICITINIB
• Medical condition to be studied:
  Dermatitis atopic

Population studied

• Age groups:
  Children (2 to < 12 years)

  Adolescents (12 to < 18 years)

  Adults (18 to < 46 years)

  Adults (46 to < 65 years)

  Adults (65 to < 75 years)

  Adults (75 to < 85 years)

  Adults (85 years and over)
• Estimated number of subjects:
  100

Study design details

• Main study objective:
  To collect long-term safety and effectiveness data on patients with atopic dermatitis treated with baricitinib in the UK.
• Data analysis plan:
  Please see ASTAR protocol for details: https://astar-register.org/clinicians-and-participating-centres/